Symmetrical dimethylarginine as the central antigenic determinant of anti-Smith autoantibodies in systemic lupus erythematosus
Annals of the Rheumatic Diseases · 2026
DOI: 10.1016/j.ard.2026.06.012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of the Rheumatic Diseases, 2026. Verfasst von Lars C van Vliet und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Arginine, Autoantibodies. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dutch Arthritis Society, Dutch Arthritis Foundation.
Abstract (Originalsprache)
OBJECTIVES: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease causing multiorgan damage. The most specific autoantibody response in SLE, present in 20% to 30% of patients, targets the Smith (Sm)-protein complex and has been shown to recognise a linear Sm-derived B cell epitope containing a posttranslational modification (PTM) of arginine termed symmetrical dimethyl arginine (sDMA). As autoantibodies to other PTM-modified proteins are often promiscuous, we aimed to determine the specificity and cross-reactivity of anti-Sm antibodies. METHODS: Specificity and promiscuity/cross-reactivity of anti-Sm immunoglobulin G (IgG) were measured using enzyme-linked immunosorbent assay in patients with SLE and healthy donors using peptides containing either sDMA or unmodified arginine. Inhibition and cross-reactivity were determined using competitive enzyme-linked immunosorbent assay and affinity purification. Recognition of endogenous Epstein-Barr nuclear antigen 1 (EBNA1) by anti-Sm IgG was performed using a Western blot of lysates of Epstein-Barr virus-bearing lymphoblastoid cell lines. RESULTS: The sDMA residue is recognised by patients with anti-Sm+ SLE regardless of the peptide amino acid sequence, with a modest impact of amino acids flanking sDMA on recognition. Most notably, IgGs targeting sDMA comprise the overall majority (∼90%) of the anti-Sm antibody repertoire and are highly cross-reactive between SmD3108-122 and several sDMA-containing viral-derived epitopes, including full-length (EBNA1). CONCLUSION: Our data implicate that the majority of anti-Sm IgGs target the sDMA residue irrespective of its Sm-context, thus representing a prototypic anti-PTM response. These antibodies are highly promiscuous, recognising several sDMA-modified targets, including naturally occurring viral sDMA-expressing epitopes. These findings suggest a new mechanism by which molecular mimicry of sDMA-modified viral proteins could contribute to a breach of tolerance in patients with anti-Sm+ SLE.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Clinical Chemistry and Laboratory Medicine, Leiden University Medical Center, Leiden, The Netherlands.
- Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands. Electronic address: j.suurmond@lumc.nl.
Förderung
- Dutch Arthritis Society
- Dutch Arthritis Foundation
Zitieren
APA
van Vliet, L. C., Dorjée, A. L., van der Heide, M., Grummels, A., van Andel, E., Steup-Beekman, G. M., Huizinga, T. W. J., Toes, R. E. M., & Suurmond, J. (2026). Symmetrical dimethylarginine as the central antigenic determinant of anti-Smith autoantibodies in systemic lupus erythematosus. Annals of the Rheumatic Diseases. https://doi.org/10.1016/j.ard.2026.06.012
Vancouver
van Vliet LC, Dorjée AL, van der Heide M, Grummels A, van Andel E, Steup-Beekman GM, et al. Symmetrical dimethylarginine as the central antigenic determinant of anti-Smith autoantibodies in systemic lupus erythematosus. Annals of the Rheumatic Diseases. 2026. doi:10.1016/j.ard.2026.06.012
BibTeX
@article{vanVliet2026,
author = {van Vliet, Lars C and Dorjée, Annemarie L and van der Heide, Martijn and Grummels, Annette and van Andel, Esther and Steup-Beekman, Gerda M and Huizinga, Thomas W J and Toes, René E M and Suurmond, Jolien},
title = {Symmetrical dimethylarginine as the central antigenic determinant of anti-Smith autoantibodies in systemic lupus erythematosus},
journal = {Annals of the Rheumatic Diseases},
year = {2026},
doi = {10.1016/j.ard.2026.06.012}
}
EUVIMED